Start typing to retrieve search suggestions. When suggestions are available use up and down arrows to review and ENTER to select. Continue typing to refine.
Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
Trusted Information Creator
Certified November 2025
{arrow_up} Back to top

Alzakt 4.6 mg/24 h Transdermal Patch

Active Ingredient:
rivastigmine
Company:  
Dr. Reddy's Laboratories (UK) Ltd See contact details
ATC code: 
N06DA03
{info_black}
About Medicine
{medical_services}
Prescription only medicine
Patient Leaflet (PIL) Risk Materials
{arrow_left}
{arrow_right}

Educational Risk Minimisation Materials to help reduce the risk associated with using this medicine.

{pdf_link}

Rivastigmine patch (Alzakt) - Instructions for use and patient diary

Rivastigmine patch (Alzakt) - Instructions for use and patient diary

You are trying to reach document intended for healthcare professionals only.

Are you a healthcare professional?

Log in or sign up to avoid further verifications.

Dr. Reddy's Laboratories (UK) Ltd
Company image
Address
Dr. Reddy's Laboratories (UK) Limited, 410 Cambridge Science Park, Milton Road, Cambridge, CB4 0PE, UK
Telephone
+44 (0)1223 728 010
Medical Information Direct Line
+44 (0)1748 828 873
Medical Information e-mail
[email protected]
Customer Care direct line
+44 (0)1223 651 475
WWW
http://www.drreddys.com/united-kingdom
E-mail
[email protected]